Fighting Cancer from Within

By Administrator at 11 Aug 2020

Among many advances in oncology over the past decade, the most striking may be the growing field of immunotherapy. The U.S. Food & Drug Administration has approved immunotherapies for some two dozen cancer types – from successful CAR T-cell therapy for acute lymphoblastic leukemia, to PD-1 checkpoint inhibitors for melanoma and non-small cell lung cancer, to therapeutic vaccines for pancreatic cancer. Thousands of clinical trials currently underway hold promise for more progress to come.

0 comments posted



    2020 2019 2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials


    Current Gateway-funded clinical trials


    Clinical trials funded at leading institutions worldwide


    Funds one patient for one day at a Gateway-funded clinical trial


    Mission Partners